User profiles for ANNE DURNEZ

Anne Durnez

Cliniques Universitaires Saint-Luc
Verified email at uclouvain.Be
Cited by 3631

[PDF][PDF] Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

…, J Heo, DF Calvisi, Z Sun, T Roskams, A Durnez… - …, 2004 - Wiley Online Library
We analyzed global gene expression patterns of 91 human hepatocellular carcinomas (HCCs)
to define the molecular characteristics of the tumors and to test the prognostic value of the …

Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease

T Roskams, SQ Yang, A Koteish, A Durnez… - The American journal of …, 2003 - Elsevier
In animals, the combination of oxidative liver damage and inhibited hepatocyte proliferation
increases the numbers of hepatic progenitors (oval cells). We studied different murine …

The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin

A Durnez, C Verslype, F Nevens, J Fevery… - …, 2006 - Wiley Online Library
Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs)
and in cholangiocytes but not in normal hepatocytes, has been reported in some …

From prolonged febrile illness to fever of unknown origin: the challenge continues

…, T Adriaenssens, W Demey, A Durnez… - Archives of internal …, 2003 - jamanetwork.com
Background Epidemiological changes and the ongoing expansion of the diagnostic
armamentarium warrant a regular update of the spectrum of diseases that present as prolonged …

Keratin 19: a key role player in the invasion of human hepatocellular carcinomas

…, J Wouters, LC van Kempen, A Durnez… - Gut, 2014 - gut.bmj.com
Objective Keratin (K)19, a biliary/hepatic progenitor cell (HPC) marker, is expressed in a
subset of hepatocellular carcinomas (HCC) with poor prognosis. The underlying mechanisms …

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis …

…, E Geens, P Geusens, J Vanhoof, A Durnez… - Annals of the …, 2017 - ard.bmj.com
Objectives Combining disease-modifying antirheumatic drugs (DMARDs) with glucocorticoids
(GCs) is an effective treatment strategy for early rheumatoid arthritis (ERA), yet the ideal …

Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort

K Briot, A Durnez, S Paternotte… - Annals of the …, 2013 - ard.bmj.com
Objectives To assess bone mineral density (BMD) at lumbar spine and hip in a large cohort
of patients with early inflammatory back pain (IBP) suggestive of axial spondyloarthritis (SpA)…

The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club

…, P Bergmann, O Bruyère, P Delanaye, A Durnez… - Osteoporosis …, 2016 - Springer
The exact role of biochemical markers of bone turnover in the management of metabolic bone
diseases remains a topic of controversy. In this consensus paper, the Belgian Bone Club …

[HTML][HTML] Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 …

…, E Geens, P Geusens, J Vanhoof, A Durnez… - Arthritis research & …, 2015 - Springer
Introduction Considering a lack of efficacy data in patients with early rheumatoid arthritis (eRA)
presenting without classical markers of poor prognosis, we compared methotrexate (MTX…

An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease

A Lemmers, T Gustot, A Durnez, S Evrard… - Clinical & …, 2009 - academic.oup.com
In chronic liver disease, high circulating interleukin (IL)-6 contrasts with a poor acute phase
response. We evaluated the impact of liver and circulating IL-6-receptor (IL-6R) forms on IL-6 …